<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Capitoli G</submitter><funding>Regione Lombardia</funding><funding>Italian Association for Cancer Research</funding><funding>Ricerca Finalizzata</funding><funding>Fondazione Gigi &amp;amp; Pupa Ferrari</funding><pagination>4156</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9028391</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(8)</volume><pubmed_abstract>Fine-needle aspiration biopsies (FNA) represent the gold standard to exclude the malignant nature of thyroid nodules. After cytomorphology, 20-30% of cases are deemed "indeterminate for malignancy" and undergo surgery. However, after thyroidectomy, 70-80% of these nodules are benign. The identification of tools for improving FNA's diagnostic performances is explored by matrix-assisted laser-desorption ionization mass spectrometry imaging (MALDI-MSI). A clinical study was conducted in order to build a classification model for the characterization of thyroid nodules on a large cohort of 240 samples, showing that MALDI-MSI can be effective in separating areas with benign/malignant cells. The model had optimal performances in the internal validation set (&lt;i>n&lt;/i> = 70), with 100.0% (95% CI = 83.2-100.0%) sensitivity and 96.0% (95% CI = 86.3-99.5%) specificity. The external validation (&lt;i>n&lt;/i> = 170) showed a specificity of 82.9% (95% CI = 74.3-89.5%) and a sensitivity of 43.1% (95% CI = 30.9-56.0%). The performance of the model was hampered in the presence of poor and/or noisy spectra. Consequently, restricting the evaluation to the subset of FNAs with adequate cellularity, sensitivity improved up to 76.5% (95% CI = 58.8-89.3). Results also suggest the putative role of MALDI-MSI in routine clinical triage, with a three levels diagnostic classification that accounts for an indeterminate gray zone of nodules requiring a strict follow-up.</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies.</pubmed_title><pmcid>PMC9028391</pmcid><funding_grant_id>Fondazione Gigi &amp;amp; Pupa Ferrari 2021</funding_grant_id><funding_grant_id>Programma degli interventi per la ripresa economica: sviluppo di nuovi accordi di collaborazione con le università per la ricerca, l'innovazione e il trasferimento tecnologico: NephropaThy</funding_grant_id><funding_grant_id>Call HUB Ricerca ed Innovazione: ImmunHUB</funding_grant_id><funding_grant_id>MFAG grant 2016- Id. 18445</funding_grant_id><funding_grant_id>POR FESR 2014-2020</funding_grant_id><funding_grant_id>GR-2019-12368592</funding_grant_id><pubmed_authors>Magni F</pubmed_authors><pubmed_authors>Pagni F</pubmed_authors><pubmed_authors>Clerici F</pubmed_authors><pubmed_authors>Galimberti S</pubmed_authors><pubmed_authors>Garancini M</pubmed_authors><pubmed_authors>Piga I</pubmed_authors><pubmed_authors>Leni D</pubmed_authors><pubmed_authors>Casati G</pubmed_authors><pubmed_authors>L'Imperio V</pubmed_authors><pubmed_authors>Capitoli G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies.</name><description>Fine-needle aspiration biopsies (FNA) represent the gold standard to exclude the malignant nature of thyroid nodules. After cytomorphology, 20-30% of cases are deemed "indeterminate for malignancy" and undergo surgery. However, after thyroidectomy, 70-80% of these nodules are benign. The identification of tools for improving FNA's diagnostic performances is explored by matrix-assisted laser-desorption ionization mass spectrometry imaging (MALDI-MSI). A clinical study was conducted in order to build a classification model for the characterization of thyroid nodules on a large cohort of 240 samples, showing that MALDI-MSI can be effective in separating areas with benign/malignant cells. The model had optimal performances in the internal validation set (&lt;i>n&lt;/i> = 70), with 100.0% (95% CI = 83.2-100.0%) sensitivity and 96.0% (95% CI = 86.3-99.5%) specificity. The external validation (&lt;i>n&lt;/i> = 170) showed a specificity of 82.9% (95% CI = 74.3-89.5%) and a sensitivity of 43.1% (95% CI = 30.9-56.0%). The performance of the model was hampered in the presence of poor and/or noisy spectra. Consequently, restricting the evaluation to the subset of FNAs with adequate cellularity, sensitivity improved up to 76.5% (95% CI = 58.8-89.3). Results also suggest the putative role of MALDI-MSI in routine clinical triage, with a three levels diagnostic classification that accounts for an indeterminate gray zone of nodules requiring a strict follow-up.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-06T19:49:35.229Z</modification><creation>2025-04-06T19:49:35.229Z</creation></dates><accession>S-EPMC9028391</accession><cross_references><pubmed>35456973</pubmed><doi>10.3390/ijms23084156</doi></cross_references></HashMap>